Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Alamar Biosciences a company powering precision proteomics to enable the earliest detection of disease today announced the expansion of its NULISAseq CNS Disease Panel to include novel assays for brainderived phosphorylated
Mesoblast global leader in allogeneic cellular medicines for inflammatory diseases today announced that it has received seven years of orphandrug exclusive approval from US Food and Drug Administration FDA for Ryoncil remestemcelL
Agilent Technologies Incannounced the recent signing of a Memorandum of Understanding MOU with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over the next five years
GSK plc and Boston Pharmaceuticals a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases today announced that they have entered into an agreement under which GSK
WuXi Biologics HK a leading global Contract Research Development and Manufacturing Organization CRDMO today announced that it has entered into an agreement with Terumo Corporation that Terumo will take over WuXi Biologics drug product DP plant in Lev...
CASI Pharmaceuticals Inca Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announced that it has entered into a definitive Equity and Assets
AbTherx Inc a biotechnology company with innovative transgenic technologies that enable and accelerate antibody discovery today announced a multiprogram antibody discovery partnership with Spice Biotechnologies
Piramal Pharma Limited a leading global pharmaceuticals and wellness company in conjunction with the SelectUSA Investment Summit commits to a M investment plan towards expanding two of the Companys US facilities
Synthego has expanded its CRISPR solutions portfolio with the launch of GMP SpCas offering researchers a powerful solution to enhance CRISPRbased therapeutic development The launch of GMP SpCas enables researchers to bundle the nuclease with INDenabl...
AstraZenecasTrixeoAerospherebudesonideglycopyrroniumformoterol fumarate or BGF already licensed for the treatment of chronic obstructive pulmonary disease COPD in adults has now been approved for use in the UK with an innovative nextgeneration propel...
